Drugs / 99mTc-Etarfolatide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03011320 | Jan → Dec 2017 | ovarian cancer | Endocyte | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-Etarfolatide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03011320 ↗ |
| Modality | Diagnostic / imaging agent | “how the tumors are imaged by the 99mTc-etarfolatide single-photon emission tomography (SPECT) or single-photon emission tomography with in-line x-ray computed tomography (SPECT/CT)” NCT03011320 ↗ |